Random effects meta-analysis showed that there is a significant difference for reduction in FPG between patients in GLP-1 analogues groups and those in the sitagliptin groups (mean difference 1.10 mmol/L, 95% CI 1.31 to 0.89, I 2 = 0%, P = 0.78) (Figure 4, Table 2)

EXCELLENT Based on 1018 reviews Suman Rathod21 June 2024Trustindex verifies that the original source of the review is Google.Krisha hospital ma me brest size mate consulting karyu d .r rajnikant sir jode Mane ghanu saru samjavyu chhe thanks sirManilala Patel21 June 2024Trustindex verifies that the original source of the review is Google.Me krisha hospital ma hair fall ni treatment lidhi chhe mane ghanu saru result madiyu chhe thanks for krisha hospitalS.k Patel20 June 2024Trustindex verifies that the original source of the review is Google.Very nice Krisha Hoshpital na all's Sister and Doctor Rajanikant parmar aap shau a mane bahuj sharsh halp Sarwish aapi mane Pahela karta atiyare bahuj sharu fil thay che Thank u so much doctor &shatap Shalam che tamne Doctor Rajanikant shahenSonu Kumari15 June 2024Trustindex verifies that the original source of the review is Google.Really happy with service

Granhall C, Donsmark M, Blicher TM et al (2019) Safety and pharmacokinetics of single and multiple ascending doses of the novel oral human GLP-1 analogue, oral semaglutide, in healthy subjects and subjects with type 2 diabetes
The best GLP-1 injection site for most users is the abdomen because it offers the most surface area, consistent subcutaneous fat depth, and convenient access